Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors

Cancer Biology and Therapy

Volumn 17, Issue 3, 2016, Pages 262-271

  Clark, Nicole C ^a   Friel, Anne M ^b   Pru, Cindy A ^a   Zhang, Ling ^b   Shioda, Toshi ^c   Rueda, Bo R ^b   Peluso, John J ^d   Pru, James K ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Breast cancer; endocrine; PGRMC1; progesterone; TNBC; xenograft

Indexed keywords

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; GESTAGEN; MESSENGER RNA; PROGESTERONE; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 1; PROGESTERONE RECEPTOR MEMBRANE COMPONENT 2; PROGESTIN AND ADIPOQ RECEPTOR 5; PROGESTIN AND ADIPOQ RECEPTOR 7; PROGESTIN AND ADIPOQ RECEPTOR 8; PROTEIN; SERPINE BINDING PROTEIN 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; PGRMC1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRIPLE NEGATIVE BREAST CANCER; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL GROWTH; IMMUNOHISTOCHEMISTRY; METABOLISM; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; RECEPTORS, PROGESTERONE; TRANSFECTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84959066229     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2016.1139240     Document Type: Article

References (77)

1. N.Howlader, A.M.Noone, M.Krapcho, J.Garshell, D.Miller, S.F.Altekruse, C.L.Kosary, M.Yu, J.Ruhl, Z.Tatalovich, et al. SEER cancer statistics review, 1975–2011. Bethseda, MD: National Cancer Institute 2014; http://seer.cancer.gov/csr/1975_2011/
2. Breast cancer: prevention and control: Breast cancer burden. World Heath Organization http://www.who.int/cancer/detection/breastcancer/en/index1.html
3. N.Howlader, S.F.Altekruse, C.I.Li, V.W.Chen, C.A.Clarke, L.A.Ries, K.A.Cronin. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst 2014; 106; PMID:24777111; http://dx.doi.org/10.1093/jnci/dju055
4. L.Chen, H.M.Linden, B.O.Anderson, C.I.Li. Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat 2014; 147:609-16; PMID:25164974; http://dx.doi.org/10.1007/s10549-014-3112-6
5. B.Manavathi, O.Dey, V.N.Gajulapalli, R.S.Bhatia, S.Bugide, R.Kumar. Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev 2013; 34:1-32; PMID:22947396; http://dx.doi.org/10.1210/er.2011-1057
6. M.Le Romancer, C.Poulard, P.Cohen, S.Sentis, J.M.Renoir, L.Corbo. Cracking the estrogen receptor's posttranslational code in breast tumors. Endocr Rev 2011; 32:597-622; PMID:21680538; http://dx.doi.org/10.1210/er.2010-0016
7. J.J.Kim, T.Kurita, S.E.Bulun. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 2013; 34:130-62; PMID:23303565; http://dx.doi.org/10.1210/er.2012-1043
8. C.H.Diep, A.R.Daniel, L.J.Mauro, T.P.Knutson, C.A.Lange. Progesterone action in breast, uterine, and ovarian cancers. J Mol Endocrinol 2015; 54: R31-53; PMID:25587053; http://dx.doi.org/10.1530/JME-14-0252
9. F.Z.Stanczyk, J.P.Hapgood, S.Winer, D.R.Mishell. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 2013; 34:171-208; PMID:23238854; http://dx.doi.org/10.1210/er.2012-1008
10. R.T.Chlebowski, S.L.Hendrix, R.D.Langer, M.L.Stefanick, M.Gass, D.Lane, R.J.Rodabough, M.A.Gilligan, M.G.Cyr, C.A.Thomson, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003; 289:3243-53; PMID:12824205; http://dx.doi.org/10.1001/jama.289.24.3243
11. R.T.Chatterton, J.P.Lydon, R.G.Mehta, E.T.Mateo, A.Pletz, V.C.Jordan. Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro. Cancer Lett 2002; 188:47-52; PMID:12406547; http://dx.doi.org/10.1016/S0304-3835(02)00461-5
12. J.P.Lydon, G.Ge, F.S.Kittrell, D.Medina, B.W.O'Malley. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res 1999; 59:4276-84; PMID:10485472
13. M.R.Moore, J.B.Spence, K.K.Kiningham, J.L.Dillon. Progestin inhibition of cell death in human breast cancer cell lines. J Steroid Biochem Mol Biol 2006; 98:218-27; PMID:16466914; http://dx.doi.org/10.1016/j.jsbmb.2005.09.008
14. E.A.Kramer, H.Seeger, B.Kramer, D.Wallwiener, A.O.Mueck. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells. Menopause 2005; 12:468-74; PMID:16037763; http://dx.doi.org/10.1097/01.GME.0000155206.53856.41
15. E.A.Kramer, H.Seeger, B.Kramer, D.Wallwiener, A.O.Mueck. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells. Eur J Obstet Gynecol Reprod Biol 2006; 129:77-83; PMID:16460873; http://dx.doi.org/10.1016/j.ejogrb.2005.12.004
16. A.Cooley, L.Matthews, S.Zelivianski, A.Hardy, J.S.Jeruss. Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro. Hum Reprod 2012; 27:146-52; PMID:22081245; http://dx.doi.org/10.1093/humrep/der378
17. J.Zhou, Q.Yu, R.Chen, H.Seeger, T.Fehm, M.A.Cahill, A.O.Mueck, H.Neubauer. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. Maturitas 2013; 76:129-33; PMID:23856385; http://dx.doi.org/10.1016/j.maturitas.2013.06.013
18. Y.T.Tang, T.Hu, M.Arterburn, B.Boyle, J.M.Bright, P.C.Emtage, W.D.Funk. PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif. J Mol Evol 2005; 61:372-80; PMID:16044242; http://dx.doi.org/10.1007/s00239-004-0375-2
19. M.A.Cahill Progesterone receptor membrane component 1: an integrative review. J Steroid Biochem Mol Biol 2007; 105:16-36; PMID:17583495; http://dx.doi.org/10.1016/j.jsbmb.2007.02.002
20. E.Falkenstein, C.Meyer, C.Eisen, P.C.Scriba, M.Wehling. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 229:86-9; PMID:8954087; http://dx.doi.org/10.1006/bbrc.1996.1761
21. C.Meyer, R.Schmid, P.C.Scriba, M.Wehling. Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem 1996; 239:726-31; PMID:8774719; http://dx.doi.org/10.1111/j.1432-1033.1996.0726u.x
22. D.Gerdes, M.Wehling, B.Leube, E.Falkenstein. Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem 1998; 379:907-11; PMID:9705155; http://dx.doi.org/10.1515/bchm.1998.379.7.907
23. J.J.Peluso, J.Romak, X.Liu. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 2008; 149:534-43; PMID:17991724; http://dx.doi.org/10.1210/en.2007-1050
24. J.J.Peluso, A.Pappalardo, R.Losel, M.Wehling. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology 2006; 147:3133-40; PMID:16513825; http://dx.doi.org/10.1210/en.2006-0114
25. D.Kaluka, D.Batabyal, B.Y.Chiang, T.L.Poulos, S.R.Yeh. Spectroscopic and mutagenesis studies of human PGRMC1. Biochemistry 2015; 54:1638-47; PMID:25675345; http://dx.doi.org/10.1021/bi501177e
26. J.J.Peluso, X.Liu, M.M.Saunders, K.P.Claffey, K.Phoenix. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1. J Clin Endocrinol Metab 2008; 93:1592-9; PMID:18319313; http://dx.doi.org/10.1210/jc.2007-2771
27. J.J.Peluso Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer. Steroids 2011; 76:903-9; PMID:21371489; http://dx.doi.org/10.1016/j.steroids.2011.02.011
28. J.J.Peluso Non-genomic actions of progesterone in the normal and neoplastic mammalian ovary. Semin Reprod Med 2007; 25:198-207; PMID:17447209; http://dx.doi.org/10.1055/s-2007-973432
29. A.M.Friel, L.Zhang, C.A.Pru, N.C.Clark, M.L.McCallum, L.J.Blok, T.Shioda, J.J.Peluso, B.R.Rueda, J.K.Pru. Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors. Cancer Lett 2015; 356:434-42; PMID:25304370; http://dx.doi.org/10.1016/j.canlet.2014.09.036
30. I.S.Ahmed, H.J.Rohe, K.E.Twist, M.N.Mattingly, R.J.Craven. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule. J Pharmacol Exp Ther 2010; 333:564-73; PMID:20164297; http://dx.doi.org/10.1124/jpet.109.164210
31. O.Selmin, G.W.Lucier, G.C.Clark, A.M.Tritscher, J.P.Vanden Heuvel, J.A.Gastel, N.J.Walker, T.R.Sutter, D.A.Bell. Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis 1996; 17:2609-15; PMID:9006096; http://dx.doi.org/10.1093/carcin/17.12.2609
32. G.Crudden, R.Loesel, R.J.Craven. Overexpression of the cytochrome p450 activator hpr6 (heme-1 domain protein/human progesterone receptor) in tumors. Tumour Biol 2005; 26:142-6; PMID:15970648; http://dx.doi.org/10.1159/000086485
33. S.U.Mir, I.S.Ahmed, S.Arnold, R.J.Craven. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients. Int J Cancer 2012; 131: E1-9; PMID:21918976; http://dx.doi.org/10.1002/ijc.26432
34. B.R.Brinkley, P.T.Beall, L.J.Wible, M.L.Mace, D.S.Turner, R.M.Cailleau. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. Cancer Res 1980; 40:3118-29; PMID:7000337
35. J.J.Peluso, X.Liu, A.Gawkowska, E.Johnston-MacAnanny. Progesterone activates a progesterone receptor membrane component 1-dependent mechanism that promotes human granulosa/luteal cell survival but not progesterone secretion. J Clin Endocrinol Metab 2009; 94:2644-9; PMID:19417032; http://dx.doi.org/10.1210/jc.2009-0147
36. J.J.Peluso, X.Liu, A.Gawkowska, V.Lodde, C.A.Wu. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression. Mol Cell Endocrinol 2010; 320:153-61; PMID:20144686; http://dx.doi.org/10.1016/j.mce.2010.02.005
37. S.Difilippantonio, Y.Chen, A.Pietas, K.Schluns, M.Pacyna-Gengelbach, N.Deutschmann, H.M.Padilla-Nash, T.Ried, I.Petersen. Gene expression profiles in human non-small and small-cell lung cancers. Eur J Cancer 2003; 39:1936-47; PMID:12932674; http://dx.doi.org/10.1016/S0959-8049(03)00419-2
38. R.B.Irby, R.L.Malek, G.Bloom, J.Tsai, N.Letwin, B.C.Frank, K.Verratti, T.J.Yeatman, N.H.Lee. Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype. Cancer Res 2005; 65:1814-21; PMID:15753379; http://dx.doi.org/10.1158/0008-5472.CAN-04-3609
39. J.J.Peluso, V.Lodde, X.Liu. Progesterone regulation of progesterone receptor membrane component 1 (PGRMC1) sumoylation and transcriptional activity in spontaneously immortalized granulosa cells. Endocrinology 2012; 153:3929-39; PMID:22719051; http://dx.doi.org/10.1210/en.2011-2096
40. J.J.Peluso Progesterone receptor membrane component 1 and its role in ovarian follicle growth. Front Neurosci 2013; 7:99; PMID:23781168; http://dx.doi.org/10.3389/fnins.2013.00099
41. J.J.Peluso, J.K.Pru. Non-canonical progesterone signaling in granulosa cell function. Reproduction 2014; 147: R169-78; PMID:24516175; http://dx.doi.org/10.1530/REP-13-0582
42. J.J.Peluso, D.Griffin, X.Liu, M.Horne. Progesterone receptor membrane component-1 (PGRMC1) and PGRMC-2 interact to suppress entry into the cell cycle in spontaneously immortalized rat granulosa cells. Biol Reprod 2014; 91:104; PMID:25253729; http://dx.doi.org/10.1095/biolreprod.114.122986
43. L.Zhang, Y.Kanda, D.J.Roberts, J.L.Ecker, R.Losel, M.Wehling, J.J.Peluso, J.K.Pru. Expression of progesterone receptor membrane component 1 and its partner serpine 1 mRNA binding protein in uterine and placental tissues of the mouse and human. Mol Cell Endocrinol 2008; 287:81-9; PMID:18440126; http://dx.doi.org/10.1016/j.mce.2008.02.012
44. V.Lodde, J.J.Peluso. A novel role for progesterone and progesterone receptor membrane component 1 in regulating spindle microtubule stability during rat and human ovarian cell mitosis. Biol Reprod 2011; 84:715-22; PMID:21148105; http://dx.doi.org/10.1095/biolreprod.110.088385
45. D.Griffin, X.Liu, C.Pru, J.K.Pru, J.J.Peluso. Expression of progesterone receptor membrane component-2 within the immature rat ovary and its role in regulating mitosis and apoptosis of spontaneously immortalized granulosa cells. Biol Reprod 2014; 91:1-11; PMID:24990806; http://dx.doi.org/10.1095/biolreprod.114.117481
46. A.M.Luciano, F.Franciosi, V.Lodde, I.Tessaro, D.Corbani, S.C.Modina, J.J.Peluso. Oocytes isolated from dairy cows with reduced ovarian reserve have a high frequency of aneuploidy and alterations in the localization of progesterone receptor membrane component 1 and aurora kinase B. Biol Reprod 2013; 88:58; PMID:23325810; http://dx.doi.org/10.1095/biolreprod.112.106856
47. X.Ruan, H.Neubauer, Y.Yang, H.Schneck, S.Schultz, T.Fehm, M.A.Cahill, H.Seeger, A.O.Mueck. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. Climacteric 2012; 15:467-72; PMID:22335423; http://dx.doi.org/10.3109/13697137.2011.648232
48. I.Persson, E.Weiderpass, L.Bergkvist, R.Bergstrom, C.Schairer. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 1999; 10:253-60; PMID:10482483; http://dx.doi.org/10.1023/A:1008909128110
49. R.K.Ross, A.Paganini-Hill, P.C.Wan, M.C.Pike. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000; 92:328-32; PMID:10675382; http://dx.doi.org/10.1093/jnci/92.4.328
50. C.Schairer, J.Lubin, R.Troisi, S.Sturgeon, L.Brinton, R.Hoover. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000; 283:485-91; PMID:10659874; http://dx.doi.org/10.1001/jama.283.4.485
51. C.I.Li, N.S.Weiss, J.L.Stanford, J.R.Daling. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 2000; 88:2570-7; PMID:10861435; http://dx.doi.org/10.1002/1097-0142(20000601)88:11%3c2570::AID-CNCR20%3e3.0.CO;2-O
52. J.E.Rossouw, G.L.Anderson, R.L.Prentice, A.Z.LaCroix, C.Kooperberg, M.L.Stefanick, R.D.Jackson, S.A.Beresford, B.V.Howard, K.C.Johnson, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-33; PMID:12117397; http://dx.doi.org/10.1001/jama.288.3.321
53. J.J.Peluso, A.Gawkowska, X.Liu, T.Shioda, J.K.Pru. Progesterone receptor membrane component-1 regulates the development and Cisplatin sensitivity of human ovarian tumors in athymic nude mice. Endocrinology 2009; 150:4846-54; PMID:19797399; http://dx.doi.org/10.1210/en.2009-0730
54. J.L.Tilly The molecular basis of ovarian cell death during germ cell attrition, follicular atresia, and luteolysis. Front Biosci 1996; 1: d1-11; PMID:9159202
55. T.M.Casey, H.Chen, K.Plaut, J.F.Chiu. Involution of mouse mammary glands during whole organ culture occurs via apoptosis of epithelial tissue. Cell Biol Int 1996; 20:763-7; PMID:8979369; http://dx.doi.org/10.1006/cbir.1996.0098
56. Z.Feng, A.Marti, B.Jehn, H.J.Altermatt, G.Chicaiza, R.Jaggi. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J Cell Biol 1995; 131:1095-103; PMID:7490285; http://dx.doi.org/10.1083/jcb.131.4.1095
57. M.N.Berg, A.M.Dharmarajan, B.J.Waddell. Glucocorticoids and progesterone prevent apoptosis in the lactating rat mammary gland. Endocrinology 2002; 143:222-7; PMID:11751613; http://dx.doi.org/10.1210/endo.143.1.8584
58. J.J.Peluso, A.Pappalardo, G.Fernandez, C.A.Wu. Involvement of an unnamed protein, RDA288, in the mechanism through which progesterone mediates its antiapoptotic action in spontaneously immortalized granulosa cells. Endocrinology 2004; 145:3014-22; PMID:14988380; http://dx.doi.org/10.1210/en.2004-0067
59. G.E.Dressing, R.Alyea, Y.Pang, P.Thomas. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors. Horm Cancer 2012; 3:101-12; PMID:22350867; http://dx.doi.org/10.1007/s12672-012-0106-x
60. C.Sueldo, X.Liu, J.J.Peluso. Progestin and adipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1) and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle. Biol Reprod 2015; PMID:26203174; http://dx.doi.org/10.1095/biolreprod.115.131508
61. P.Thomas, Y.Pang, J.Dong. Enhancement of cell surface expression and receptor functions of membrane progestin receptor alpha (mPRalpha) by progesterone receptor membrane component 1 (PGRMC1): evidence for a role of PGRMC1 as an adaptor protein for steroid receptors. Endocrinology 2014; 155:1107-19; PMID:24424068; http://dx.doi.org/10.1210/en.2013-1991
62. A.L.Hughes, D.W.Powell, M.Bard, J.Eckstein, R.Barbuch, A.J.Link, P.J.Espenshade. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell Metab 2007; 5:143-9; PMID:17276356; http://dx.doi.org/10.1016/j.cmet.2006.12.009
63. J.C.Mallory, G.Crudden, B.L.Johnson, C.Mo, C.A.Pierson, M.Bard, R.J.Craven. Dap1p, a heme-binding protein that regulates the cytochrome P450 protein Erg11p/Cyp51p in Saccharomyces cerevisiae. Mol Cell Biol 2005; 25:1669-79; PMID:15713626; http://dx.doi.org/10.1128/MCB.25.5.1669-1679.2005
64. G.Crudden, R.E.Chitti, R.J.Craven. Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J Pharmacol Exp Ther 2006; 316:448-55; PMID:16234411; http://dx.doi.org/10.1124/jpet.105.094631
65. X.Zhu, Y.Han, Z.Fang, W.Wu, M.Ji, F.Teng, W.Zhu, X.Yang, X.Jia, C.Zhang. Progesterone protects ovarian cancer cells from cisplatin-induced inhibitory effects through progesterone receptor membrane component 1/2 as well as AKT signaling. Oncol Rep 2013; 30:2488-94; PMID:23970345
66. L.Liu, J.Wang, L.Zhao, J.Nilsen, K.McClure, K.Wong, R.D.Brinton. Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology 2009; 150:3186-96; PMID:19359388; http://dx.doi.org/10.1210/en.2008-1447
67. R.A.Hand, N.Jia, M.Bard, R.J.Craven. Saccharomyces cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian membrane-associated progesterone receptor. Eukaryot Cell 2003; 2:306-17; PMID:12684380; http://dx.doi.org/10.1128/EC.2.2.306-317.2003
68. Y.Maeda, H.Ohtsuka, M.Tomioka, M.Oikawa. Effect of progesterone on Th1/Th2/Th17 and regulatory T cell-related genes in peripheral blood mononuclear cells during pregnancy in cows. Vet Res Commun 2013; 37:43-9; PMID:23203561; http://dx.doi.org/10.1007/s11259-012-9545-7
69. C.I.Herold, C.K.Anders. New targets for triple-negative breast cancer. Oncology (Williston Park) 2013; 27:846-54; PMID:24282978
70. I.S.Ahmed, H.J.Rohe, K.E.Twist, R.J.Craven. Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity. J Biol Chem 2010; 285:24775-82; PMID:20538600; http://dx.doi.org/10.1074/jbc.M110.134585
71. J.Aizen, P.Thomas. Role of Pgrmc1 in estrogen maintenance of meiotic arrest in zebrafish oocytes through Gper/Egfr. J Endocrinol 2015; 225:59-68; PMID:25720537; http://dx.doi.org/10.1530/JOE-14-0576
72. H.Neubauer, G.Adam, H.Seeger, A.O.Mueck, E.Solomayer, D.Wallwiener, M.A.Cahill, T.Fehm. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells. Climacteric 2009; 12:230-9; PMID:19340614; http://dx.doi.org/10.1080/13697130802635637
73. M.Swiatek-De Lange, A.Stampfl, S.M.Hauck, H.Zischka, C.J.Gloeckner, C.A.Deeg, M.Ueffing. Membrane-initiated effects of progesterone on calcium dependent signaling and activation of VEGF gene expression in retinal glial cells. Glia 2007; 55:1061-73; PMID:17551930; http://dx.doi.org/10.1002/glia.20523
74. J.Moffat, D.A.Grueneberg, X.Yang, S.Y.Kim, A.M.Kloepfer, G.Hinkle, B.Piqani, T.M.Eisenhaure, B.Luo, J.K.Grenier, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006; 124:1283-98; PMID:16564017; http://dx.doi.org/10.1016/j.cell.2006.01.040
75. S.L.S.T.Smith. Advantages of COS-1 monkey kidney epithelial cells as packaging host for small-volume production of high-quality recombinant lentiviruses. J Virol Methods 2009; 157:47-54; PMID:19118578; http://dx.doi.org/10.1016/j.jviromet.2008.12.002
76. J.K.Pru, M.P.Lynch, J.S.Davis, B.R.Rueda. Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003; 1:17; PMID:12646059; http://dx.doi.org/10.1186/1477-7827-1-17
77. M.M.Jensen, J.T.Jorgensen, T.Binderup, A.Kjaer. Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper. BMC Med Imaging 2008; 8:16; PMID:18925932; http://dx.doi.org/10.1186/1471-2342-8-16